A pharmacokinetics study of nicotine for B-001 in healthy adult male smokers
Not Applicable
- Conditions
- Smokers
- Registration Number
- JPRN-UMIN000017297
- Lead Sponsor
- JAPAN TOBACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
- Subjects who have used smoking cessation medications within 4 weeks of the screening, or plan to use the medication until the end of the study - Subjects whose blood was collected more than 200 ml within 4 weeks prior to the screening, or more than 400 ml within 12weeks prior to the screening (including blood donation) etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method icotine pharmacokinetic parameters (Cmax, Tmax and AUClast)
- Secondary Outcome Measures
Name Time Method